Published in Health Business Week, October 20th, 2006
Net sales increased 5% to $508,161,000. Operating income increased 2% to $155,043,000 from $151,410,000, and on an adjusted basis increased 7% to $159,269,000. Net income increased 2% to $102,830,000 from $100,299,000. and increased 6% on an adjusted basis to $106,815,000. Diluted earnings per share increased 5% to $0.42 from $0.40, and increased 10% on an adjusted basis to $0.44. Reported earnings per share for the first quarter of fiscal year 2007 includes a $.02 per share impact related to SFAS 123 Share-Based Payment.
Effective June 1,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.